An outbreak of Ebola in eastern Democratic Republic of Congo should be eradicated by the end of 2019, Congolese President Felix Tshisekedi said on Friday.
Shares of drug developer ResTORbio Inc plunged more than 80% to a record low on Friday after a late-stage trial failure prompted the company to abandon testing its lead drug as a treatment for respiratory illness.
Swiss drugmaker Roche is paying up to $1.4 billion to buy U.S. biotech company Promedior, whose main drug candidate against the lung disease idiopathic pulmonary fibrosis is set to begin late-stage trials, Promedior said on Friday.
GlaxoSmithKline said further growth from its shingles vaccine, which has boosted earnings, would be reined in by limited capacity until 2024, but a new bioreactor facility would then be ready to bring a step change in production.
ResTORbio Inc said on Friday it had stopped testing its lead drug as a treatment for respiratory illness after it failed to meet the main goal in a late-stage trial, sending the company's shares down nearly 70%.
Jazz Pharmaceuticals Plc's treatment for a form of sleep disorder has been recommended for approval in Europe by a panel of the European Medicines Agency (EMA), the regulator said on Friday.
Pakistan began vaccinating millions of children against typhoid on Friday to try to control a drug-resistant superbug outbreak of the fever that has already infected some 11,000 people since 2016 and risks spreading internationally.
GlaxoSmithKline said further growth from its shingles vaccine, which has boosted earnings, would be reined in by limited capacity until 2024, but a new bioreactor facility would then be ready to bring a "step change" in production.
Wu Zhen, a former deputy head of China's food and drug regulator, was sentenced to 16 years in prison by a Chinese court, state television reported on Friday.
The U.S. Food and Drug Administration on Thursday approved BeiGene Ltd's lymphoma treatment, validating the China-based drugmaker's strategy of largely using data from trials held outside the United States to file for approval.